Cipla Limited (CIPLA.NS)

1.347,30 -27,90 (-2,03%) Al cierre: 03:30PM IST

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com

Sector(es): Healthcare
Sector: Drug Manufacturers - General
Empleados a tiempo completo: 32.323

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Umang Vohra B.E., M.B.A.	MD, Global CEO & Executive Director	174,9M	N/A	1971
Dr. Raju Sunil Mistry M.A., Ph.D.	President & Global Chief People Officer	N/A	N/A	1965
Mr. Pradeep Bhadauria	President & Chief Scientific Officer	N/A	N/A	N/A
Mr. Ashish Adukia	Global Chief Financial Officer	N/A	N/A	N/A
Mr. Dinesh Ramniranjan Jain	Senior VP & Head of Corporate Finance	N/A	N/A	N/A
Ms. Geena V. Malhotra	Global Chief Technology Officer	N/A	N/A	N/A
Mr. Naveen Bansal	Head of Investor Relations	N/A	N/A	N/A
Mr. Rajendra Kumar Chopra	Compliance Officer & Company Secretary	15,3M	N/A	N/A
Ms. Heena Kanal	Senior Vice-President of Corporate Communications	N/A	N/A	N/A
Mr. Anurag Mishra	Head of Cipla Foundation	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en INR.

Descripción

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Gobierno corporativo

El ISS Governance QualityScore de Cipla Limited, a día 1 de abril de 2024, es 4. Las puntuaciones base son Auditoría: 4; Tablero: 3; Derechos de los accionistas: 1; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.